Our study demonstrated that young Filipino women (≤40-year-old) with breast cancer were diagnosed with a higher pathologic grade and stage, had more IDC pathology, hormonal receptor negativity, high Ki67 status and TNBC molecular subtypes, and had more adjuvant chemo- and radiotherapy when compared with older patients. This evidence concerns the gene MKI67 and breast carcinoma.